Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI

NCT04391322 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Group 1: Healthy Controls
Group 2: Stable CF
Group 3: CF Participants Anticipated to Receive CFTR-modulator Therapy
Group 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy

Sponsor

The Hospital for Sick Children